Page last updated: 2024-10-28

hydroxyurea and Ichthyosis

hydroxyurea has been researched along with Ichthyosis in 1 studies

Ichthyosis: Any of several generalized skin disorders characterized by dryness, roughness, and scaliness, due to hypertrophy of the stratum corneum epidermis. Most are genetic, but some are acquired, developing in association with other systemic disease or genetic syndrome.

Research Excerpts

ExcerptRelevanceReference
"Hydroxyurea is an anti-tumour agent most commonly used to treat chronic myeloproliferative disorders in doses up to 4 g per day."5.31Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. ( Kaur, I; Kumar, B; Saraswat, A, 2002)
"Hydroxyurea is an anti-tumour agent most commonly used to treat chronic myeloproliferative disorders in doses up to 4 g per day."1.31Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. ( Kaur, I; Kumar, B; Saraswat, A, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumar, B1
Saraswat, A1
Kaur, I1

Other Studies

1 other study available for hydroxyurea and Ichthyosis

ArticleYear
Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients.
    Clinical and experimental dermatology, 2002, Volume: 27, Issue:1

    Topics: Adult; Aged; Drug Eruptions; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Hydroxyurea; Icht

2002